[1]
S. Batra, R. Arora, and K. Dave, “Predictive value of changes in the serum CA-125 levels in patients undergoing interval debulking surgery after neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma”, Int J Reprod Contracept Obstet Gynecol, vol. 8, no. 2, pp. 483–487, Jan. 2019.